Cancer immunotherapy approach targets common genetic alteration
Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are ...
Mar 15, 2021
0
101